Imxia AT 5% Solution is a topical formulation combining Minoxidil 5% w/v, Azelaic Acid 1.5% w/v, and Tretinoin 0.01% w/v, designed for the management of androgenetic alopecia and related hair loss conditions. Minoxidil, a potent vasodilator, promotes hair follicle stimulation and prolongs the anagen phase, thereby enhancing hair regrowth. Azelaic Acid possesses anti-inflammatory and antimicrobial properties, contributing to the reduction of follicular inflammation and inhibition of 5-alpha-reductase activity, which decreases dihydrotestosterone (DHT) levels implicated in hair follicle miniaturization. Tretinoin, a retinoid, facilitates increased percutaneous absorption of Minoxidil and promotes epidermal turnover, further supporting follicular health and hair regrowth. Imxia AT 5% Solution is applied topically to the affected scalp areas once or twice daily as directed by a healthcare professional. Patients should avoid contact with eyes and mucous membranes and discontinue use if irritation or hypersensitivity occurs. This combination therapy offers a multifaceted approach to hair loss by addressing vascular, hormonal, and cellular factors involved in alopecia. It is contraindicated in individuals with hypersensitivity to any component and should be used cautiously during pregnancy and lactation. Consultation with a healthcare provider is recommended prior to initiation.